EGFR and non-small cell lung carcinoma: MEHD7945A activity in vivo was tested in twelve xenograft models of various origin (NSCLC, ovarian, breast, pancreas, colorectal) in parallel with treatments with monospecific monoclonals against EGFR (cetuximab) or against ErbB3.